Members
Representative Sponsor | Yukari Tanaka |
---|---|
Caretaker | Junji Komaba |
Caretaker | Kosuke Saito |
Caretaker | Masatsugu Maekawa |
Caretaker | Naoaki Murao |
Caretaker | Eishi Mukai |
Caretaker | Katsunori Iemaki |
Caretaker | Emi Kamiyama |
Overview
In addition to conventional small molecules and macromolecules, the development of new modalities of pharmaceuticals represented by cells and nucleic acids and the use of biomarkers for drug development have been actively pursued in recent years. In this DIS, we will discuss the current status and issues of diversified analytical and imaging techniques to properly evaluate the pharmacokinetics of these drugs in the body.